We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.25B
AUM Growth
+$636M
Cap. Flow
+$222M
Cap. Flow %
5.22%
Top 10 Hldgs %
17.16%
Holding
2,498
New
632
Increased
436
Reduced
368
Closed
712

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$119M
2
PFE icon
Pfizer
PFE
+$60.7M
3
CRM icon
Salesforce
CRM
+$48.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.6M
5
TSLA icon
Tesla
TSLA
+$20.5M

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Technology 9.75%
3 Healthcare 8.93%
4 Consumer Discretionary 7.52%
5 Real Estate 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
1826
CALL
Axsome Therapeutics
AXSM
$11B
-61,000
Closed -$2.01M
AZN icon
1827
CALL
AstraZeneca
AZN
$250B
-5,050
Closed -$607K
AZN icon
1828
AstraZeneca
AZN
$250B
-32,578
Closed -$3.91M
AZO icon
1829
AutoZone
AZO
$50.1B
-325
Closed -$552K
BARK.WS
1830
DELISTED
BARK Inc Warrants
BARK.WS
-29,286
Closed -$201K
BB icon
1831
BlackBerry
BB
$5.12B
-30,120
Closed -$293K
BBWI icon
1832
CALL
Bath & Body Works
BBWI
$4.19B
-5,000
Closed -$315K
BBWI icon
1833
PUT
Bath & Body Works
BBWI
$4.19B
-5,300
Closed -$334K
BCAB icon
1834
BioAtla
BCAB
$5.53M
-508
Closed -$748K
BCRX icon
1835
CALL
BioCryst Pharmaceuticals
BCRX
$2.31B
-32,200
Closed -$463K
BCYC
1836
CALL
Bicycle Therapeutics
BCYC
$277M
-13,000
Closed -$541K
BIDU icon
1837
Baidu
BIDU
$37.7B
-2,048
Closed -$315K
BILL icon
1838
PUT
BILL Holdings
BILL
$4.81B
-12,200
Closed -$3.26M
BIO icon
1839
Bio-Rad Laboratories Class A
BIO
$9.31B
-373
Closed -$278K
BKD icon
1840
Brookdale Senior Living
BKD
$3.45B
-18,315
Closed -$115K
BKSY icon
1841
BlackSky Technology
BKSY
$1.03B
-1,866
Closed -$155K
BLK icon
1842
Blackrock
BLK
$176B
-371
Closed -$311K
BMBL icon
1843
Bumble
BMBL
$397M
-29,449
Closed -$1.47M
BNTX icon
1844
BioNTech
BNTX
$23.3B
-1,500
Closed -$411K
BPMC
1845
DELISTED
Blueprint Medicines
BPMC
-2,596
Closed -$267K
BRO icon
1846
Brown & Brown
BRO
$23.7B
-32,501
Closed -$1.8M
BSM icon
1847
CALL
Black Stone Minerals
BSM
$3.09B
-257,100
Closed -$3.1M
BSY icon
1848
Bentley Systems
BSY
$10.9B
-5,000
Closed -$303K
BWMX icon
1849
Betterware México
BWMX
$641M
-32,572
Closed -$1.16M
BZ icon
1850
Kanzhun
BZ
$7.23B
-6,453
Closed -$232K

Similar funds

Boothbay Fund Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boothbay Fund Management held 2,498 positions worth $4.25B, up 18% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management deployed $222M of net new capital in Q4 2021, opening 632 new positions and adding to 436 existing holdings. Its largest new stake was Pfizer: 1,225,403 shares worth $72.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12.6M trimmed.

  • Boothbay Fund Management's largest Q4 2021 buy was Pfizer: 1,225,403 shares worth $72.4M.
  • Boothbay Fund Management added most to Amazon in Q4 2021, an estimated $119M increase.
  • Boothbay Fund Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $12.6M.
  • Boothbay Fund Management fully exited Digital World Acquisition Corp. Units in Q4 2021, selling an estimated $24.6M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.25B portfolio in Q4 2021.
  • Boothbay Fund Management opened 632 new positions and closed 712 in Q4 2021.
  • Boothbay Fund Management's portfolio value rose 18% quarter-over-quarter to $4.25B.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.